title: Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
abstract: BACKGROUND
  Colorectal cancer (CRC) is a heterogeneous disease that, on the molecular level, can be characterized by inherent genomic instabilities; chromosome instability and microsatellite instability. In the present study we analyze genome-wide disruption of pre-mRNA splicing, and propose transcriptome instability as a characteristic that is analogous to genomic instability on the transcriptome level.
  
  
  METHODS
  Exon microarray profiles from two independent series including a total of 160 CRCs were investigated for their relative amounts of exon usage differences. Each exon in each sample was assigned an alternative splicing score calculated by the FIRMA algorithm. Amounts of deviating exon usage per sample were derived from exons with extreme splicing scores.
  
  
  RESULTS
  There was great heterogeneity within both series in terms of sample-wise amounts of deviating exon usage. This was strongly associated with the expression levels of approximately half of 280 splicing factors (54% and 48% of splicing factors were significantly correlated to deviating exon usage amounts in the two series). Samples with high or low amounts of deviating exon usage, associated with overall transcriptome instability, were almost completely separated into their respective groups by hierarchical clustering analysis of splicing factor expression levels in both sample series. Samples showing a preferential tendency towards deviating exon skipping or inclusion were associated with skewed transcriptome instability. There were significant associations between transcriptome instability and reduced patient survival in both sample series. In the test series, patients with skewed transcriptome instability showed the strongest prognostic association (P = 0.001), while a combination of the two characteristics showed the strongest association with poor survival in the validation series (P = 0.03).
  
  
  CONCLUSIONS
  We have described transcriptome instability as a characteristic of CRC. This transcriptome instability has associations with splicing factor expression levels and poor patient survival.
authors: Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, PO Box 4953 Nydalen, NO-0424 Oslo, Norway. rolf.i.skotheim@rr-research.no.
authors: Anita
authors: A
authors: Sveen
authors: Trude H
authors: TH
authors: Agesen
authors: Arild
authors: A
authors: Nesbakken
authors: Torleiv O
authors: TO
authors: Rognum
authors: Ragnhild A
authors: RA
authors: Lothe
authors: Rolf I
authors: RI
authors: Skotheim
references: Science. 1995 Jun 2;268(5215):1336-8
references: 7761852
references: Bioinformatics. 2009 Jan 15;25(2):288-9
references: 19033274
references: Biostatistics. 2003 Apr;4(2):249-64
references: 12925520
references: Exp Mol Pathol. 2008 Aug;85(1):64-7
references: 18482722
references: Histopathology. 2007 Jan;50(1):113-30
references: 17204026
references: PLoS Comput Biol. 2008 Mar 14;4(3):e1000011
references: 18369415
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D169-74
references: 18836194
references: Gastroenterology. 2008 May;134(5):1296-310
references: 18471507
references: Genet Mol Res. 2004 Dec 30;3(4):512-20
references: 15688317
references: J Biol Chem. 2001 May 11;276(19):16411-7
references: 11278482
references: PLoS One. 2009;4(3):e4732
references: 19266097
references: Cell. 1996 Oct 18;87(2):159-70
references: 8861899
references: Expert Rev Mol Diagn. 2008 May;8(3):277-88
references: 18598107
references: Int J Biochem Cell Biol. 2007;39(7-8):1432-49
references: 17416541
references: Nat Genet. 2008 Dec;40(12):1413-5
references: 18978789
references: Nat Struct Mol Biol. 2006 Jun;13(6):472-4
references: 16757943
references: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
references: 10411935
references: Cell. 2006 Jul 14;126(1):37-47
references: 16839875
references: Bioinformatics. 1998;14(8):656-64
references: 9789091
references: Bioinformatics. 2008 Aug 1;24(15):1707-14
references: 18573797
references: Mol Cell Proteomics. 2011 Jan;10(1):M110.002998
references: 20938052
references: Nat Genet. 2000 May;25(1):25-9
references: 10802651
references: Nature. 2008 Nov 27;456(7221):470-6
references: 18978772
references: Trends Genet. 2001 Feb;17(2):100-7
references: 11173120
references: Nucleic Acids Res. 2003 Jul 1;31(13):3784-8
references: 12824418
references: Int J Cancer. 2010 Dec 15;127(12):2893-917
references: 21351269
references: Cancer Res. 2004 Nov 1;64(21):7647-54
references: 15520162
references: Gastroenterology. 2002 May;122(5):1376-87
references: 11984524
references: Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):710-5
references: 10639144
references: PLoS Genet. 2006 Nov 24;2(11):e207; author reply e208
references: 17121470
references: Nucleic Acids Res. 2009 Aug;37(14):4873-86
references: 19546110
references: BMC Bioinformatics. 2008 Dec 29;9:559
references: 19114008
references: BMC Genomics. 2006 Dec 27;7:325
references: 17192196
references: Nature. 1993 Jun 10;363(6429):558-61
references: 8505985
references: Nat Rev Mol Cell Biol. 2009 Nov;10(11):741-54
references: 19773805
references: Gastroenterology. 2001 Dec;121(6):1275-80
references: 11729105
references: Pac Symp Biocomput. 2004;:66-77
references: 14992493